ID
12560
Description
A Randomized, Double-blind, Placebo-controlled Clinical Study of the Oral IL-12/23 Inhibitor, STA-5326 Mesylate, Administered to Patients With Rheumatoid Arthritis to Determine Safety, Tolerability, Pharmacokinetic and Synovial Tissue Outcomes; ODM derived from: https://clinicaltrials.gov/show/NCT00642629
Link
https://clinicaltrials.gov/show/NCT00642629
Keywords
Versions (1)
- 11/30/15 11/30/15 -
Uploaded on
November 30, 2015
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Active, Moderate to Severe Rheumatoid Arthritis NCT00642629
Eligibility Active, Moderate to Severe Rheumatoid Arthritis NCT00642629
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
is taking any disease-modifying anti-rheumatic drug (dmard) other than mtx
Data type
boolean
Alias
- UMLS CUI [1,1]
- C2347852
- UMLS CUI [1,2]
- C0242708
Description
positive (≥10 mm) tuberculin (ppd) skin test
Data type
boolean
Alias
- UMLS CUI [1]
- C3161220
Description
has received any investigational drug or experimental procedure for the treatment of ra
Data type
boolean
Alias
- UMLS CUI [1]
- C2348568
Description
(e.g., renal, hepatic, neurological, cardiovascular, pulmonary, endocrine, psychiatric, hematologic, urologic, or other acute or chronic illness)
Data type
boolean
Alias
- UMLS CUI [1]
- C0525058
- UMLS CUI [2]
- C0439801
- UMLS CUI [3]
- C0009488
Similar models
Eligibility Active, Moderate to Severe Rheumatoid Arthritis NCT00642629
- StudyEvent: Eligibility
C0001779 (UMLS CUI [2])
C0750934 (UMLS CUI [2])
C0205360 (UMLS CUI [1,2])
C0006147 (UMLS CUI [1,2])
C0700589 (UMLS CUI [2])
C0242708 (UMLS CUI [1,2])
C0439801 (UMLS CUI [2])
C0009488 (UMLS CUI [3])